What is the effect of dihydropyridine CCB use compared to placebo on graft loss?
The evidence review found that dihydropyridine CCB use caused a statistically significant reduction in graft loss compared to placebo (RR: 0.56; 95% CI: 0.35 0.90). The evidence was derived from 8 RCTs involving 926 participants followed for a mean of 25 months.